GGrantIndex
Sort

85,873 grants matching alzheimers

BIN1, Interneuron Activity, and Network Dysfunction in Alzheimer Disease

$2,606,674
Erik D Roberson · University Of Alabama At Birmingham · RF1 · FY2018 · AG

Project 3 -- MIDUS Biomarker Project

$2,606,494
Carol D. Ryff · University Of Wisconsin-Madison · U19 · FY2022 · AG

Alzheimer's Disease Research Center

$2,605,095
Leon J Thal · University Of California, San Diego · P50 · FY2006 · AG

Project 3 -- MIDUS Biomarker Project

$2,604,263
Carol D. Ryff · University Of Wisconsin-Madison · U19 · FY2024 · AG

Risk Factors, Pathology, and Clinical Expressions of AD

$2,603,054
David A Bennett · Rush University Medical Center · R01 · FY2020 · AG

A role for mitochondrial AMPK signaling in neurons

$2,602,940
Tommy L Lewis · Oklahoma Medical Research Foundation · RF1 · FY2025 · AG

Neurovascular unit dysfunction in Down syndrome revealed by TBI

$2,601,812
Mingxia Huang · University Of Colorado Denver · RF1 · FY2022 · NS

Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias

$2,601,749
Jeffery W Kelly · Scripps Research Institute, The · RF1 · FY2021 · AG

p53, Aging, and Cancer

$2,600,582
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease

$2,599,447
Huntington Potter · University Of Colorado Denver · R01 · FY2023 · AG

Mitochondrial transport and energy metabolism in synaptic transmission and neuronal degeneration and regeneration

$2,598,611
Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Arterial Stiffness, Cognition, and Equol (ACE)

$2,598,271
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG

Advancing the Lives & HeaLth of Youth and Young Adults with Down Syndrome (ALLY-DS)

$2,598,199
Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · U01 · FY2024 · HD

Repository Core

$2,597,082
Lee-Way Jin · University Of California At Davis · U19 · FY2021 · NS

Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease

$2,595,120
Chunyu Wang · Rensselaer Polytechnic Institute · RF1 · FY2020 · AG

Forward Genetic Analysis of Innate Immune Signaling

$2,594,659
Bruce A Beutler · Scripps Research Institute, The · U19 · FY2016 · AI

Core B Clinical

$2,593,785
Marilyn S Albert · Johns Hopkins University · U19 · FY2022 · AG

Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD

$2,593,144
Sua Myong · Johns Hopkins University · RF1 · FY2020 · AG

Arterial Stiffness, Cognition, and Equol (ACE)

$2,591,586
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG

Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease

$2,591,567
Xiangmin Xu · University Of California-Irvine · U01 · FY2025 · AG

Alzheimer's Disease Research Center

$2,591,473
Thomas J Montine · University Of Washington · P50 · FY2013 · AG

Swedish APP mutation and NMJ decline in Alzheimer's disease

$2,591,248
Wen-Cheng Xiong · Case Western Reserve University · RF1 · FY2020 · AG

The complex interaction between Alzheimer drivers and aging

$2,591,132
Kenneth S Kosik · University Of California Santa Barbara · RF1 · FY2020 · AG

Fyn Inhibition by AZD0530 for Alzheimers Disease

$2,590,082
Stephen M Strittmatter · Yale University · UH3 · FY2016 · TR

Epidemiology of Dementia In An Urban Community

$2,589,384
Columbia University Health Sciences · P01 · FY2005 · AG